Accelerated fibrosis in individuals co-infected with hepatitis C virus (HCV) and individual immunodeficiency virus (HIV) is a major reason behind mortality in the highly energetic anti-retroviral therapy (HAART) era. HIV/HCV co-infection. Launch Hepatitis C pathogen (HCV) and individual immunodeficiency pathogen (HIV) affect around 150 million and 35 million people world-wide, respectively[1, 2]. Considering that both… Continue reading Accelerated fibrosis in individuals co-infected with hepatitis C virus (HCV) and